Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease
- PMID: 30530069
- DOI: 10.1016/j.msard.2018.12.005
Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources